What is NDC 68071-2263?

68071-2263 is the product NDC for Lisinopril and Hydrochlorothiazide, Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide Tablets).

What is the active ingredient?

Lisinopril, Hydrochlorothiazide.

NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisinopril and Hydrochlorothiazide?

85 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisinopril and Hydrochlorothiazide NDC 68071-2263

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-2263Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-2263Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-2263-9	6807122630968071226309	90 TABLET in 1 BOTTLE (68071-2263-9)Marketed from Sep 16, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril and Hydrochlorothiazide
Generic name (nonproprietary): lisinopril and hydrochlorothiazide tablets
Active ingredients: Lisinopril — 20 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.NDC labeler code 68071
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204058
Marketing start: Dec 26, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 68071-2263_1d767dc0-5343-f00c-e063-6394a90a4e6eSPL ID 1d767dc0-5343-f00c-e063-6394a90a4e6eSPL set ID af74c331-7402-408c-e053-2a95a90a1043RxCUI 197886UNII E7199S1YWR, 0J48LPH2THUPC 0368071226393
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071226309 followed by a unit qualifier and the quantity

Package 68071-2263-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lisinopril and hydrochlorothiazide tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68071-2263

What is NDC 68071-2263?: 68071-2263 is the product NDC for Lisinopril and Hydrochlorothiazide, Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide Tablets).
What is the active ingredient?: Lisinopril, Hydrochlorothiazide.
Who is the labeler?: NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisinopril and Hydrochlorothiazide?: 85 other product NDCs are listed under this name. See all Lisinopril and Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisinopril and Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0433	67046-0433-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4516	70518-4516-0070518-4516-01
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-564	51407-0564-0551407-0564-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-565	51407-0565-0551407-0565-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	GSMS, Incorporated	51407-566	51407-0566-0551407-0566-90
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-586	60760-0586-90
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0207	80425-0207-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8253	68788-8253-0168788-8253-0368788-8253-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8224	68788-8224-0168788-8224-0368788-8224-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-3505	70518-3505-0070518-3505-0170518-3505-02+1 more

All 86 Lisinopril and Hydrochlorothiazide NDCs

Other NDCs under ANDA 204058

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204058
Product	Strength	Form · route	Labeler	Product NDC
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Exelan Pharmaceuticals, Inc.	76282-446
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Exelan Pharmaceuticals, Inc.	76282-447
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Exelan Pharmaceuticals, Inc.	76282-448
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Cipla USA Inc.	69097-968
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Cipla USA Inc.	69097-969
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Cipla USA Inc.	69097-971
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Bryant Ranch Prepack	71335-1992
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-382
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-374
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-383
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Bryant Ranch Prepack	71335-1783
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	A-S Medication Solutions	50090-6094
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2291
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2303